Mitochondrial reactive oxygen species generation sites (mROS generation sites)

Mitochondrial reactive oxygen species (mROS) generation sites refer to specific locations within the mitochondrial electron transport chain (ETC) where electrons prematurely reduce molecular oxygen to form superoxide (O2•−) or hydrogen peroxide (H2O2) [Brand, 2010]. The most prominent sites include the flavin mononucleotide (FMN) site of Complex I (Site IF), the ubiquinone-binding site of Complex I (Site IQ), and the outer ubiquinone-binding site of Complex III (Site IIIQo) [Murphy, 2009]. While low levels of mROS are essential for physiological redox signaling, excessive production is a primary driver of oxidative damage in various pathologies [Brand, 2016]. These sites are considered therapeutic targets for mitigating oxidative stress without compromising the overall bioenergetic capacity of the cell. Pharmacological intervention involves the use of mitochondria-targeted antioxidants like MitoQ or site-specific suppressors of electron leak (S1QELs and S3QELs) that specifically block ROS production at one site without affecting electron flow through the rest of the ETC [Orr et al., 2015]. Targeting these sites is particularly relevant for treating neurodegenerative diseases, cardiovascular disorders, and ischemia-reperfusion injury [Smith & Murphy, 2010].

Other names

Mitochondrial electron transport chain ROS production sitesmROS sitesETC superoxide generation sitesMitochondrial redox centers

Site-specific suppression of electron leak or scavenging of reactive oxygen species within the mitochondrial matrix and intermembrane space.